Article info
PDFOriginal research
General medicine
TIDieR checklist evaluation of clinical trial intervention reporting for recent FDA-approved anticancer medications
- Correspondence to Cole Wayant, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107, USA; cole.wayant{at}okstate.edu
Citation
TIDieR checklist evaluation of clinical trial intervention reporting for recent FDA-approved anticancer medications
Publication history
- Accepted October 15, 2019
- First published October 25, 2019.
Online issue publication
May 25, 2020
Article Versions
- Previous version (21 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.